To verify our speculation, we tested the expression of SMAD2/3 and p-SMAD2/3 in PC cells after the knockdown of USP33, our experiment demonstrated that USP33 elevated the expression of p-SMAD2/3 with no alteration in protein level of SMAD2/3. This evidence concerns the gene SMAD2 and pachyonychia congenita.